BRKR

Bruker Corporation

55
Fundamentals46/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential32/ 100

BRKR lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.

BRKR Fundamentals

MetricStatus
Stable
Under pressure
Healthy
Weak

BRKR's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.

BRKR PE Valuation

BRKR has no meaningful PE right now: it lost money over the past year.

BRKR Forward outlook

MetricOutlook
--
Strong growth
Stable
Strongly improving
Limited
High

Analysts expect BRKR's earnings to grow and its profitability to improve, with its revenue holding steady.

BRKR Risk to reward

ScenarioChangePrice
Upside+50%$90.52
Downside-32%$40.76

Calculated from the latest close: $60.33 on Nov 12.

BRKR's one-year upside scenario is somewhat larger than its downside: +50% against −32%.

BRKR Earnings Per Share

Q4 2024: $0.76Q1 2025: $0.52Q2 2025: $0.52Q3 2025: $-0.16Q4 2025: $-0.15Q1 2026: $-0.24Q2 2026: $-0.70Q3 2026: $-1.10Forward: $2.34
Q4 2024: $0.76Q1 2025: $0.52Q2 2025: $0.52Q3 2025: $-0.16Q4 2025: $-0.15Q1 2026: $-0.24Q2 2026: $-0.70Q3 2026: $-1.10Forward: $2.34
QuarterTTM EPSYoY
Forward$2.34—
Q3 2026-$1.10-$0.94
Q2 2026-$0.70-235%
Q1 2026-$0.24-146%
Q4 2025-$0.15-120%
Q3 2022$1.82+3.4%
Q2 2022$1.80+17%
Q1 2022$1.85+40%
Q4 2021$1.81+77%

BRKR lost $1.10 per share over the past year, and its loss has widened in each of the last three quarters.

BRKR Quarterly Revenue

Q4 2023: $855MQ1 2024: $722MQ2 2024: $801MQ3 2024: $864MQ4 2024: $980MQ1 2025: $801MQ2 2025: $797MQ3 2025: $861MQ4 2025: $977MQ1 2026: $823MQ2 2026: $839MQ3 2026: $874M
Q4 2023: $855MQ1 2024: $722MQ2 2024: $801MQ3 2024: $864MQ4 2024: $980MQ1 2025: $801MQ2 2025: $797MQ3 2025: $861MQ4 2025: $977MQ1 2026: $823MQ2 2026: $839MQ3 2026: $874M
QuarterRevenueYoY
Q3 2026$874M+1.6%
Q2 2026$838.5M+5.2%
Q1 2026$823.4M+2.7%
Q4 2025$977.2M-0.2%
Q3 2025$860.5M-0.5%
Q2 2025$797.4M-0.4%
Q1 2025$801.4M+11%
Q4 2024$979.6M+15%

BRKR's revenue grew through 2024 and has held roughly level since: $874M last quarter, up 1.6% from the same quarter a year ago.

BRKR Free Cash Flow

Q4 2023: $174MQ1 2024: $400,000Q2 2024: −$24MQ3 2024: $6MQ4 2024: $153MQ1 2025: $39MQ2 2025: −$149MQ3 2025: −$54MQ4 2025: $207MQ1 2026: $47MQ2 2026: −$106MQ3 2026: $97M
Q4 2023: $174MQ1 2024: $400,000Q2 2024: −$24MQ3 2024: $6MQ4 2024: $153MQ1 2025: $39MQ2 2025: −$149MQ3 2025: −$54MQ4 2025: $207MQ1 2026: $47MQ2 2026: −$106MQ3 2026: $97M
QuarterFree cash flowYoY
Q3 2026$96.7M+$150.8M
Q2 2026-$106.2M+$42.6M
Q1 2026$47M+21%
Q4 2025$207.2M+35%
Q3 2025-$54.1M-1033%
Q2 2025-$148.8M-$125.3M
Q1 2025$39M+9650%
Q4 2024$153.3M-12%

BRKR's free cash flow has turned positive again: $245M over the past year, against −$11M the year before.

BRKR Total Shares

Q2 2025: 152MQ3 2025: 152MQ4 2025: 152MQ1 2026: 153MQ2 2026: 152MQ3 2026: 153M
Q2 2025: 152MQ3 2025: 152MQ4 2025: 152MQ1 2026: 153MQ2 2026: 152MQ3 2026: 153M
PeriodChange %Net change
Quarterly+0.1%+200K shares
1 year+0.5%+700K shares
3 years-1.9%-2.9M shares

BRKR has 153M diluted shares, about the same as a year ago.

BRKR Net Leverage

Q4 2023: 1.4xQ1 2024: 2.1xQ2 2024: 4.1xQ3 2024: 4.8xQ4 2024: 4.4xQ1 2025: 4.6xQ2 2025: 5.9xQ3 2025: 6.2xQ4 2025: 5.4xQ1 2026: 5.6xQ2 2026: 8.2xQ3 2026: 10.0x
Q4 2023: 1.4xQ1 2024: 2.1xQ2 2024: 4.1xQ3 2024: 4.8xQ4 2024: 4.4xQ1 2025: 4.6xQ2 2025: 5.9xQ3 2025: 6.2xQ4 2025: 5.4xQ1 2026: 5.6xQ2 2026: 8.2xQ3 2026: 10.0x
QuarterNet LeverageStatus
Q3 202610.0xHigh
Q2 20268.2xHigh
Q1 20265.6xHigh
Q4 20255.4xHigh
Q3 20256.2xHigh
Q2 20255.9xHigh
Q1 20254.6xHigh
Q4 20244.4xHigh

BRKR's net debt is about 10 years of its operating earnings (EBITDA), up from 6.2 years a year ago.

BRKR Weekly Momentum

MetricValueStatus
RSI55.3Neutral
Stochastic52.9Neutral

BRKR's weekly RSI is 55 (neutral) and its Stochastic is 53 (neutral).

BRKR PE vs Healthcare Sector

MetricBRKRSector medianRelative
PEN/A26x—

BRKR has no meaningful PE right now: it lost money over the past year.

BRKR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$59.71.1% above
20 week MA$59.12.1% above
50 week MA$50.420% above
100 week MA$46.430% above
200 week MA$58.33.6% above

BRKR has climbed back above all five of its weekly moving averages, and it's now 3.6% above its 200-week average.

BRKR Yearly ROI

YearStart priceEnd priceROI
2020$51.0$54.3+6.6%
2021$54.3$80.3+48%
2022$80.3$66.5-17%
2023$66.5$73.5+10%
2024$73.5$58.4-21%
2025$58.4$48.0-18%
2026 YTD$48.0$60.3+26%

BRKR has finished lower in three of the last six years. It's up 26% so far in 2026.

Give your agent the market.

Get API key